# US 6,727,286 B2 · Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,286 B2
- Document ID: US6727286B2
- Status: Granted
- Kind: B2
- Application number: 09/985,246
- Filed: 2001-11-02
- Published: 2003-05-29
- Granted: 2004-04-27
- Earliest claimed: 2001-11-02
- Assignees: Cumberland Pharmaceuticals Inc.
- Inventors: Leo Pavliv
- Web page: https://patentgrep.com/patent/US6727286B2

## CPC

- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 9/19: lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides a pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than 1:1, as well as a method of making the same. The present invention also provides a method of treating a condition chosen from pain, inflammation, fever, and/or other conditions alleviated by ibuprofen comprising administering a pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than 1:1.

## Claims

### Claim 1

A pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than or equal to 0.97:1.

### Claim 2 (depends on 1)

The pharmaceutical composition of claim 1, wherein the aqueous solution of arginine and ibuprofen has been terminally sterilized.

### Claim 3 (depends on 1)

The pharmaceutical composition of claim 1, wherein the aqueous solution of arginine and ibuprofen has been lyophilized.

### Claim 4 (depends on 1)

The pharmaceutical composition of claim 1, wherein the ibuprofen is (RS)-Ibuprofen.

### Claim 5 (depends on 1)

The pharmaceutical composition of claim 1, wherein the ibuprofen is (S)-Ibuprofen.

### Claim 6 (depends on 1)

The pharmaceutical composition of claim 1, wherein the arginine is L-arginine.

### Claim 7 (depends on 1)

The pharmaceutical composition of claim 1, wherein the arginine is D-arginine.

### Claim 8 (depends on 1)

The pharmaceutical composition of claim 1, wherein the molar ratio of arginine to ibuprofen is from about 0.10:1 to about 0.97:1.

### Claim 9 (depends on 8)

The pharmaceutical composition of claim 8, wherein the molar ratio of arginine to ibuprofen is 0.92:1.

### Claim 10 (depends on 8)

The pharmaceutical composition of claim 8, wherein the molar ratio of arginine to ibuprofen is 0.60:1.

### Claim 11 (depends on 8)

The pharmaceutical composition of claim 8, wherein the molar ratio of arginine to ibuprofen is 0.97:1.

### Claim 12

A method of making a pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen, the method comprising dissolving arginine in water to form an arginine solution and dissolving ibuprofen in the arginine solution to form the aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than or equal to 0.97:1.

### Claim 13 (depends on 12)

The method of claim 12, wherein the molar ratio of arginine to ibuprofen is from about 0.10:1 to about 0.97:1.

### Claim 14 (depends on 12)

The method of claim 12, wherein the molar ratio of arginine to ibuprofen is 0.92:1.

### Claim 15 (depends on 12)

The method of claim 12, wherein the molar ratio of arginine to ibuprofen is 0.60:1.

### Claim 16 (depends on 12)

The method of claim 12, wherein the molar ratio of arginine to ibuprofen is 0.97:1.

### Claim 17 (depends on 12)

The method of claim 12, further comprising terminally sterilizing the aqueous solution of arginine and ibuprofen.

### Claim 18 (depends on 12)

The method of claim 12, further comprising lyophilizing the aqueous solution of arginine and ibuprofen.

### Claim 19 (depends on 12)

The method of claim 12, wherein the ibuprofen is (RS)-Ibuprofen.

### Claim 20 (depends on 12)

The method of claim 12, wherein the ibuprofen is (S)-Ibuprofen.

### Claim 21 (depends on 12)

The method of claim 12, wherein the arginine is L-arginine.

### Claim 22 (depends on 12)

The method of claim 12, wherein the arginine is D-arginine.

### Claim 23

A method of treating one or more conditions chosen from pain, inflammation, fevers, and, patent ductus arteriosis comprising administering to a patient in need thereof an effective amount of an aqueous solution of arginine and ibuprofen, wherein the molar ratio of arginine to ibuprofen is less than or equal to 0.97:1.

### Claim 24 (depends on 23)

The method of claim 23, wherein the molar ratio of arginine to ibuprofen is from about 0.10:1 to about 0.97:1.

### Claim 25 (depends on 23)

The method of claim 23, wherein the molar ratio of arginine to ibuprofen is 0.92:1.

### Claim 26 (depends on 23)

The method of claim 23, wherein the molar ratio of arginine to ibuprofen is 0.60:1.

### Claim 27 (depends on 23)

The method of claim 23, wherein the molar ratio of arginine to ibuprofen is 0.97:1.

### Claim 28 (depends on 23)

The method of claim 23, wherein the administration occurs via intravenous injection.

### Claim 29 (depends on 23)

The method of claim 23, wherein the administration occurs via intramuscular injection.

### Claim 30 (depends on 23)

The method of claim 23, wherein the administration occurs orally.

### Claim 31 (depends on 23)

The method of claim 23, wherein the effective amount is from about 100 mg to about 800 mg of ibuprofen.

### Claim 32 (depends on 31)

The method of claim 31, wherein the effective amount is about 400 mg of ibuprofen.

### Claim 33 (depends on 23)

The method of claim 23, wherein the effective amount is about 7.5 mg/kg of ibuprofen.

### Claim 34 (depends on 23)

The method of claim 23, wherein the condition is pain.

### Claim 35 (depends on 23)

The method of claim 23, wherein the condition is inflammation.

### Claim 36 (depends on 23)

The method of claim 23, wherein the condition is fever.

### Claim 37 (depends on 12)

A pharmaceutical composition comprising an aqueous solution of arginine and ibuprofen prepared according to the method of claim 12.

### Claim 38 (depends on 23)

The method of claim 23, wherein the condition is patent ductus arteriosis.

### Claim 39 (depends on 1)

The pharmaceutical composition of claim 1, the molar ratio of arginine to ibuprofen is from about 0.60:1 to about 0.97:1.

### Claim 40 (depends on 39)

The pharmaceutical composition of claim 39, wherein said molar ratio is from about 0.92:1 to about 0.97:1.

### Claim 41 (depends on 12)

The method of claim 12, wherein the molar ratio of arginine to ibuprofen is from about 0.60:1 to about 0.97:1.

### Claim 42 (depends on 41)

The method of claim 41, wherein the molar ratio of arginine to ibuprofen is from about 0.92:1 to about 0.97:1.

### Claim 43 (depends on 23)

The method of claim 23, wherein the molar ratio of arginine to ibuprofen is from about 0.60:1 to about 0.97:1.

### Claim 44 (depends on 43)

The method of claim 43, wherein the molar ratio of arginine to ibuprofen is from about 0.92:1 to about 0.97:1.
